ctrl K

Watchlist Price Alert

Seelos Therapeutics Inc. (SEEL)

NASDAQ: SEEL · Real-Time Price · USD

0.37

null (null%)

At close: Nov 18, 2024, 9:58 PM

Seelos Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	2.2M	n/a	n/a	n/a	375K	n/a	n/a	5.76M
Cost of Revenue	30.12M	53K	n/a	n/a	22.56M	n/a	117K	3.89M
Gross Profit	-27.91M	-53K	n/a	n/a	-22.19M	n/a	-117K	1.87M
Operating Income	-40.5M	-70.92M	-61.67M	-18.76M	-29.75M	-9.15M	-10.68M	-13.41M
Interest Income	198K	121K	113K	45K	151K	n/a	n/a	n/a
Pretax Income	-37.88M	-73.53M	-66.05M	-19.1M	-50.88M	-9.22M	-11.75M	-7.43M
Net Income	-37.88M	-76.14M	-67.53M	-19.22M	-50.38M	-9.24M	321K	-7.43M
Selling & General & Admin	12.53M	12.3M	15.02M	7.78M	7.56M	7.93M	7.21M	8.43M
Research & Development	30.12M	58.62M	46.65M	10.98M	22.56M	1.22M	3.46M	6.83M
Other Expenses	n/a	-3.02M	230K	n/a	-375K	1K	77K	-22K
Operating Expenses	12.59M	70.92M	61.67M	18.76M	29.75M	9.15M	10.67M	15.27M
Interest Expense	75K	14K	1.6M	164K	29K	n/a	83K	1.02M
Selling & Marketing Expenses	-57K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	42.7M	70.92M	61.67M	18.76M	29.75M	9.15M	10.67M	19.16M
Income Tax Expense	n/a	2.6M	1.49M	119K	-497K	-70K	-11.91M	1M
Shares Outstanding (Basic)	4.9M	3.54M	3.03M	1.49M	676.96K	102.72K	13.2K	110.27K
Shares Outstanding (Diluted)	4.9M	3.54M	3.03M	1.49M	676.96K	102.72K	13.2K	110.27K
EPS (Basic)	-7.73	-21.48	-22.29	-12.88	-74.43	-89.97	24.32	-67.41
EPS (Diluted)	-7.73	-21.48	-22.29	-12.88	-74.43	-89.97	24.32	-67.41
EBITDA	-37.75M	-73.47M	n/a	n/a	-29.33M	-3.14M	-10.56M	-6.11M
EBIT	-37.81M	-73.52M	-64.45M	-18.94M	-27.75M	-3.34M	-10.67M	-6.21M
Depreciation & Amortization	57K	53K	61.67M	18.76M	41K	41K	117K	106K